Bioorg Med Chem Lett. 2009 Mar 1;19(5):1403-8. Epub 2009 Jan 19.

N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.

Wang H, Yu N, Song H, Chen D, Zou Y, Deng W, Lye PL, Chang J, Ng M, Sun ET, Sangthongpitag K, Wang X, Wu X, Khng HH, Fang L, Goh SK, Ong WC, Bonday Z, Stünkel W, Poulsen A, Entzeroth M.

Source

S *BIO Pte Ltd, 1 Science Park Road, #05-09 The Capricorn, Singapore Science Park II, Singapore 117528, Singapore.

Abstract

A series of N-hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides were designed and synthesized as novel HDAC inhibitors. General SAR has been established for the substituents at positions 1 and 2, as well as the importance of the ethylene group and its attachment to position 5. Optimized compounds are much more potent than SAHA in both enzymatic and cellular assays. A representative compound, 23 (SB639), has demonstrated antitumor activity in a colon cancer xenograft model.

PMID:: 19181524; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Chemical Information

BindingDB

Supplemental Content

Related citations

Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity. [Bioorg Med Chem Lett. 2010]
Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity.
Bressi JC, de Jong R, Wu Y, Jennings AJ, Brown JW, O'Connell S, Tari LW, Skene RJ, Vu P, Navre M, et al. Bioorg Med Chem Lett. 2010 May 15; 20(10):3138-41. Epub 2010 Mar 30.
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). [J Med Chem. 2003]
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).
Remiszewski SW, Sambucetti LC, Bair KW, Bontempo J, Cesarz D, Chandramouli N, Chen R, Cheung M, Cornell-Kennon S, Dean K, et al. J Med Chem. 2003 Oct 9; 46(21):4609-24.
2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors. [J Med Chem. 2007]
2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.
Mahboobi S, Sellmer A, Höcher H, Garhammer C, Pongratz H, Maier T, Ciossek T, Beckers T. J Med Chem. 2007 Sep 6; 50(18):4405-18. Epub 2007 Aug 11.
Review Histone deacetylase inhibitors: the Abbott experience. [Curr Med Chem. 2003]
Review Histone deacetylase inhibitors: the Abbott experience.
Curtin M, Glaser K. Curr Med Chem. 2003 Nov; 10(22):2373-92.
Review Recent progress in the development of assays suited for histone deacetylase inhibitor screening. [Mol Genet Metab. 2003]
Review Recent progress in the development of assays suited for histone deacetylase inhibitor screening.
Wegener D, Hildmann C, Schwienhorst A. Mol Genet Metab. 2003 Sep-Oct; 80(1-2):138-47.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone de...
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
Bioorg Med Chem Lett. 2009 Mar 1 ;19(5):1403-8. Epub 2009 Jan 19 .

PubMed
Differential diagnosis and imaging in Cushing's syndrome.
Differential diagnosis and imaging in Cushing's syndrome.
Endocrinol Metab Clin North Am. 2005 Jun ;34(2):403-21, x.

PubMed
Uninsured hospitalizations: rural and urban differences.
Uninsured hospitalizations: rural and urban differences.
J Rural Health. 2008 Spring ;24(2):194-202.

PubMed
Thrombophilia and cancer.
Thrombophilia and cancer.
Pathophysiol Haemost Thromb. 2008 ;36(3-4):131-6. Epub 2009 Jan 27 .

PubMed
Reporter gene transfer induces apoptosis in primary cortical neurons.
Reporter gene transfer induces apoptosis in primary cortical neurons.
Mol Ther. 2002 Jun ;5(6):723-30.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Chemical Information

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information